摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,4Z,6aR)-2-[1,3-dibenzyl-2,3,3a,4,6,6a-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-ylidene]-ethane | 1041865-17-1

中文名称
——
中文别名
——
英文名称
(3aS,4Z,6aR)-2-[1,3-dibenzyl-2,3,3a,4,6,6a-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-ylidene]-ethane
英文别名
(3aS,4Z,6aR)-4-ethylidenetetrahydro-1,3-bis(phenylmethyl)-1H-thieno[3,4-d]imidazol-2(3H)-one
(3aS,4Z,6aR)-2-[1,3-dibenzyl-2,3,3a,4,6,6a-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-ylidene]-ethane化学式
CAS
1041865-17-1
化学式
C21H22N2OS
mdl
——
分子量
350.484
InChiKey
XFSVUAQQWAKZHF-SGBYLJFBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.51
  • 重原子数:
    25.0
  • 可旋转键数:
    4.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    23.55
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (3aS,6aR)-1,3-dibenzyl-4-ethyl-4-hydroxytetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one盐酸 作用下, 以 甲苯 为溶剂, 反应 1.0h, 以1 mg的产率得到(3aS,4Z,6aR)-2-[1,3-dibenzyl-2,3,3a,4,6,6a-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-ylidene]-ethane
    参考文献:
    名称:
    (+)-生物素侧链引入过程中(3aS,6aR)-γ-硫内酯部分的意外环扩展
    摘要:
    乙烯基溴化镁与(3a S,6a R)-γ-硫代内酯2在THF中反应后,在γ-硫代内酯部分发生意外的环扩环后,七元环酮5的收率极高,而不是预期的叔醇3。
    DOI:
    10.1002/hlca.200800435
点击查看最新优质反应信息

文献信息

  • A Practical Synthesis of Multifunctional Ketones through the Fukuyama Coupling Reaction
    作者:Yoshikazu Mori、Masahiko Seki
    DOI:10.1002/adsc.200600610
    日期:2007.8.6
    A highly efficient, robust and scalable protocol for the synthesis of multifunctional ketones through Fukuyama coupling, i.e., cross-coupling of thiol esters with zinc reagents, has been developed. Treatment of thiol esters with alkylzinc iodides or dialkyl zincs in the presence of palladium on activated carbon (Pd/C) or palladium acetate [Pd(OAc)2] furnished the corresponding ketones in high yields
    已经开发出一种通过福山偶联法合成酮的高效,稳健和可扩展的方案,即硫醇酯锌试剂的交叉偶联。在活性炭(Pd / C)或乙酸[Pd(OAc)2 ]存在下,用烷基碘化锌或二烷基处理硫醇酯可提供相应的酮,收率很高。对Pd / C催化反应的性质-活性关系的评估已证明,在代内酯1a与锌试剂2a反应中,氧化Pd / C比还原的Pd / C更有效。。基于Pd / C催化反应对Pd / C性质的依赖性以及Pd从Pd / C浸出到溶液中的程度,Pd / C催化福山偶联反应的双重反应机理提出了包括多相和均相催化循环的方法。当添加溴化锌时,锌试剂的显着减少和Pd(OAc)2的使用量大大减少。这支持一个假设,其中从无效二烷基(R施兰克平衡的移位2 Zn)的活性有机锌物种,例如烷基卤化物(RZnX)和三个坐标物种[(RZnX 2)- ⋅(ZNX)+在反应期间生成稳定的单体Pd络合物可以促进反应。
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-4-羟基-4-(3-甲氧基丙基)四氢-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3aS-顺式)-1,3-二苄基四氢-4-(3-甲氧基丙亚基)-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 3,4-(N-Monobenzyl-2'-oxoimidazolido)-2-(4-hydroxybutyl)-thiophan (1R,3R)-3-Cyclopentylidenemethyl-2,2-dimethyl-cyclopropanecarboxylic acid 2,5-dioxo-3-prop-2-ynyl-imidazolidin-1-ylmethyl ester (+/-)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium; chloride cis 1,3-Dibenzyl-4-diphenylphosphinoylmethyl-2,3,3a,4,6,6a-hexahydrofuro<3,4-d>imidazol-2-one 7-[3-(3-hydroxy-3-methyl-nonyl)-1-methyl-2,5-dioxo-imidazolidin-4-yl]-heptanoic acid ethyl ester biotin thioacetate 5-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-selenolo[3,4-d]imidazol-4t-yl)-pentanoic acid 2,5,5-trioxo-(3ar,6ac)-hexahydro-5λ6-thieno[3,4-d]imidazole-1-carboxylic acid ethyl ester (1'S,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one [4-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-butyl]-carbamic acid 2-(2-hydroxy-ethoxy)-ethyl ester biotin thiol (3aS,4S,6aR)-4-(6-bromohexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (1'R,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 6-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]hexanenitrile (S)-α-<<3aR-(3aα,4α,6aα)>-2-Hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-thieno<3,4-d>imidazol-4-yloxy>benzeneacetic acid 3,4-(1,3-Diallyl-2-oxoimidazolido)-thiophan cis-N-benzylperhydrothieno<3,4-d>imidazole-2-one 5,5-dioxide 3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionic acid 6,6-dioxo-(4ar,7ac)-hexahydro-6λ6-thieno[3,4-d]pyrimidine-2,4-dione (3aα,4α,6aα)-1,3-dibenzylhexahydro-4-(pentyloxy)-1H-thieno<3,4-d>imidazol-2(3H)-one 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-thiophanvaleronitril 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 3-(1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde 1,3-dibenzyl-4,6,7,8,8a,8b-hexahydro-3aH-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide (3aS)-1,3-dibenzyl-4t-(3-hydroxy-propyl)-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one (3aR)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium, (1R)-2-oxo-bornane-10-sulfonate 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2-enoic acid methyl ester 3,3a,4,6,7,8,8a,8b-octahydro-1H-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide 5ξ-hydroxy-(2ar,7ac,7bc)-hexahydro-1-thia-3,4a-diaza-cyclopenta[cd]inden-4-one 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2t-enoic acid methyl ester 1,3-Dibenzyl-6-(bis-phenylsulfanyl-methyl)-tetrahydro-thieno[3,4-d]imidazol-2-one (4Z)-1-ethyl-5-imino-4-({3-methoxy-4-[(2-methylbenzyl)oxy]phenyl}methylidene)imidazolidin-2-one [3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propyl]-malonic acid (3aS,6aR)-1-Allyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one 3-(2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde oxime cis-(3a,6a)-1,3-di-n-butylhexahydro-1H-thieno<3,4-d>imidazole 5,5-dioxide